Dundee, United Kingdom

Gian Filippo Ruda

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 24(Granted Patents)


Location History:

  • Dundee, GB (2009 - 2011)
  • Oxford, GB (2015)

Company Filing History:


Years Active: 2009-2015

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Gian Filippo Ruda

Introduction

Gian Filippo Ruda is a notable inventor based in Dundee, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of four patents to his name, Ruda's work focuses on developing compounds that have potential therapeutic applications.

Latest Patents

One of Ruda's latest patents is related to morpholino compounds, which are derivatives that serve as antagonists, reverse agonists, or agonists of G-protein coupled receptors, such as dopamine D4 and 5HT1a. This invention includes pharmaceutical compositions that utilize these compounds, which may be beneficial in treating neurological and neurodegenerative diseases. Another significant patent involves Dutpase inhibitors, which are deoxyuridine derivatives designed to enhance therapeutic efficacy.

Career Highlights

Throughout his career, Gian Filippo Ruda has worked with reputable organizations, including Medivir AB and the University of Dundee. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Ruda has collaborated with various professionals in his field, including Ian Gilbert and Corinne Nguyen. These partnerships have facilitated the development of his innovative ideas and patents.

Conclusion

Gian Filippo Ruda's contributions to pharmaceutical innovations highlight his expertise and dedication to advancing medical science. His patents reflect a commitment to addressing critical health challenges through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…